The Quantellect read.As of Nov 19, 2026, 19 active firms cover Johnson & Johnson: 12 rate it Buy or better, 7 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets span $208.00 to $320.00, a moderate spread. The average target of $272.22 sits 2% above the current $266.95. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $2.67 next quarter toward $11.62 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS19 active firms
Buy
Strong Buy00%
Buy1263%
Neutral737%
Sell00%
Strong Sell00%
Based on 19 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$272.22
+2.0% upside
Average target across 18 active firms as of Nov 19, 2026 vs $266.95 current
Highest Target$320.00
Average Target$272.22
Lowest Target$208.00
Detailed analyst forecasts for JNJ
Showing 1–21 of 21 named analysts shown · 19 active firms in the rating projection
As of Nov 19, 2026, 12 of 19 active firms rate JNJ a Buy (7 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
JNJ EPS & revenue forecast
EPS · NEXT QUARTER
$2.67
Range $2.57 – $2.87 · 7 analysts · -1% YoY
Next period, 7 analysts expect Johnson & Johnson to earn $2.67 a share (range $2.57 – $2.87), versus $2.70 a year earlier. Full-year consensus is $11.12, growing to $11.62 the year after.
REVENUE · NEXT QUARTER
$25.6B
Range $25.3B – $26.2B · 7 analysts · +6% YoY
Revenue is expected to reach $25.6B (range $25.3B – $26.2B), +6.2% year-over-year. Full-year consensus is $101.2B, rising to $107.8B next year.
Top analysts covering Johnson & Johnson
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on JNJ.
#1
Joanne Wuensch
Citigroup · Rank #35
Buy
$303.00+13.5% to target
Overall win rate
51%
+ Follow
#2
Jason Gerberry
B of A Securities · Rank #160
Neutral
$275.00+3.0% to target
Overall win rate
47%
+ Follow
#3
JB
Jayson Bedford
Raymond James · Rank #191
Buy
$265.00-0.7% to target
Overall win rate
44%
+ Follow
#4
Vamil Divan
Guggenheim · Rank #211
Buy
$287.00+7.5% to target
Overall win rate
48%
+ Follow
#5
Terence Flynn
Morgan Stanley · Rank #222
Buy
$292.00+9.4% to target
Overall win rate
36%
+ Follow
JNJ stock forecast FAQ
What is JNJ's average 12-month price target?+
The 18 active firms with a live target average $272.22 for Johnson & Johnson over the next 12 months, ranging from a $320.00 high to a $208.00 low, as of Nov 19, 2026.
Is JNJ stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 19 active firms as of Nov 19, 2026, 12 rate it Buy or Strong Buy, 7 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for JNJ?+
The Street-high target is $320.00 (HSBC), and the Street-low is $208.00 (Bernstein). The average of all 18 active-firm targets is $272.22.
How many active Wall Street firms cover JNJ?+
19 active firms have a recognized rating on Johnson & Johnson as of Nov 19, 2026, and 18 active firms carry a live 12-month price target.
Who is the most accurate analyst covering JNJ?+
Among analysts who currently cover JNJ, Joanne Wuensch of Citigroup has the strongest overall Quantellect track record (Rank #35). Their current call is Buy with a $303.00 target.
What is Johnson & Johnson's projected EPS for next quarter?+
The consensus estimate is $2.67 per share (range $2.57 – $2.87) across 7 analysts. Full-year EPS is projected at $11.12, rising to $11.62 the following year.
How much revenue is Johnson & Johnson expected to report next quarter?+
Consensus revenue is $25.6B (range $25.3B – $26.2B). Full-year revenue is projected at $101.2B, growing to $107.8B next year.
Have analysts been upgrading or downgrading JNJ lately?+
As of Nov 19, 2026, 12 of 19 active firms rate JNJ a Buy (7 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their JNJ calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.